Name
AS TFTAK
Registry code
11930972
VAT number
EE101379478
Type
AS - Joint Stock Company
Status
Registered
Foundation date
23.04.2010 (14)
Financial year
01.01-31.12
Capital
39 375.00 €
Activity
72111 - Research and experimental development on biotechnology
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| OÜ Bioexpert 10075074 | 20% - 7 875.00 EUR | - | - | FounderShareholder |
| AS Laser Diagnostic Instruments 10390775 | 20% - 7 875.00 EUR | - | - | FounderShareholder |
| Tallinna Tehnikaülikool 74000323 | 20% - 7 875.00 EUR | - | - | FounderShareholder |
| AKTSIASELTS SALUTAGUSE PÄRMITEHAS 10423925 | 40% - 15 750.00 EUR | - | - | FounderShareholder |
| Martin Lall
| - | Board member | - | |
| David Ashley Clark
| - | - | - | Board member |
| Ildar Nisamedtinov
| - | - | - | Board member |
| Kristo Reinsalu
| - | - | - | Board member |
| Kuldar Leis
| - | - | - | Board member |
| Aavo Sõrmus
| - | - | - | Chairman of the board |
| AS PRFoods 11560713 | - | - | - | Founder |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | 663 317.2 € | 347 074.41 € | 341 236.49 € | 84 |
| 2024 Q3 | 431 096.81 € | 339 045.62 € | 363 330.04 € | 82 |
| 2024 Q2 | 916 681.39 € | 339 065.54 € | 346 218.79 € | 81 |
| 2024 Q1 | 992 582.3 € | 309 344.76 € | 330 836.51 € | 82 |
| 2023 Q4 | 669 877.64 € | 325 857.85 € | 335 862.46 € | 87 |
| 2023 Q3 | 624 873.38 € | 338 560.87 € | 343 521.25 € | 87 |
| 2023 Q2 | 856 227.37 € | 310 357.09 € | 319 636.16 € | 98 |
| 2023 Q1 | 1 069 992.28 € | 334 110.21 € | 356 325.05 € | 97 |
| 2022 Q4 | 785 267.33 € | 323 432.51 € | 346 096.1 € | 107 |
| 2022 Q3 | 865 803.69 € | 333 051.75 € | 354 656.22 € | 114 |
| 2022 Q2 | 726 218.81 € | 322 539.23 € | 310 337.64 € | 115 |
| 2022 Q1 | 597 915.46 € | 282 425.2 € | 294 600.11 € | 107 |
| 2021 Q4 | 1 001 242.87 € | 281 951.58 € | 274 546.67 € | 99 |
| 2021 Q3 | 916 953.22 € | 245 227.76 € | 261 597.06 € | 93 |
| 2021 Q2 | 537 570.79 € | 225 554.58 € | 242 137.18 € | 92 |
| 2021 Q1 | 808 388.3 € | 245 393.44 € | 239 783.61 € | 92 |
| 2020 Q4 | 549 704.05 € | 220 598.16 € | 225 888.19 € | 90 |
| 2020 Q3 | 1 026 958 € | 219 726.11 € | 235 525.27 € | 83 |
| 2020 Q2 | 454 296.32 € | 195 411.15 € | 203 970.38 € | 84 |
| 2020 Q1 | 548 081.54 € | 203 119.15 € | 199 031.75 € | 77 |
